News & Alerts
-
Jan- 2024 -6 January
Sarepta Triumphs Over Regenxbio and UPenn in Patent Lawsuit for Duchenne Muscular Dystrophy Treatment
Delaware federal court ruled in favor of Sarepta Therapeutics, bringing an end to a patent lawsuit filed by Regenxbio and…
Read More » -
6 January
Ligand Pharma’s At-Home Viral Skin Infection Treatment Gains U.S. Approval
Ligand Pharmaceuticals Inc. has announced that its topical treatment for a viral skin infection, Zelsuvmi, has received approval from the…
Read More » -
6 January
Florida Becomes U.S. First State to Get FDA’s Approval to Import Cheaper Prescription Drug from Canada
On Friday, Florida achieved a landmark authorization from the U.S. Food and Drug Administration (FDA) to directly import prescription drugs…
Read More » -
6 January
Wegovy and Ozempic Not Linked to Increase in Suicidal Thoughts, U.S. Study Finds
A comprehensive U.S. study has revealed that there is no evidence to suggest a connection between the usage of Novo…
Read More » -
6 January
Global Single-cell Analysis Technology Market Report 2023
ResearchAndMarkets a leading market research provider, announces the release of the “Single-cell Analysis: Technology Growth Opportunities” report, offering a comprehensive…
Read More » -
6 January
Comprehensive Analysis of Emerging Therapies and Innovations in Obesity Drugs and Delivery Platforms
ResearchAndMarket a leading market research provider, has released a comprehensive report titled “Growth Opportunities in Obesity Drugs and Delivery Platforms,”…
Read More » -
5 January
Jordan Conducts Airstrikes on Suspected Iranian-Backed Drug Smugglers in Syria
In a significant move, Jordan conducted air strikes within Syria on Thursday, targeting suspected warehouses and hideouts believed to be…
Read More » -
5 January
Merck Explores Broader Health Benefits Beyond Weight Loss in GLP-1 Treatments
Merck & Co (MRK.N) is exploring GLP-1 treatments that offer benefits beyond weight loss, according to CEO Robert Davis. GLP-1…
Read More » -
5 January
Elevance Health Set For Strategic Acquisition of Paragon Healthcare for Over $1 Billion
Elevance Health (ELV.N) is set to acquire private firm Paragon Healthcare for a sum exceeding $1 billion, according to sources…
Read More » -
5 January
Dr. John N. van den Anker Assumes Role of Editor-in-Chief for The Journal of Clinical Pharmacology
The American College of Clinical Pharmacology (ACCP) has announced the appointment of Dr. John N. van den Anker, MD, PhD,…
Read More »